APC News

FTC won’t probe PBMs

Published February 18, 2022

It won't look into their practices without a clearer proposal.

Meta-analysis contradicts faulty NASEM report

Published February 18, 2022

A new paper finds there is simply no evidence that compounded hormones pose an increased clinical risk compared to FDA-approved products.

FDA doubles down on NASEM report

Published February 18, 2022

Lest you think FDA’s threat to restrict compounded hormones (based on that deeply flawed NASEM report) was idle talk, check out the letter the agency sent to 22 members of Congress.

FDA warns about compounded ketamine nasal spray

Published February 18, 2022

It's issued an alert to patients and providers.

High-five to Cheri

Published February 18, 2022

She was ready for her close-up.

The State of the Alliance in 2022

Published February 7, 2022

Where does APC stand? Our leadership explains.

APC leaders meet with FDA officials

Published February 4, 2022

The discussion, with FDA CDER officials, covered a lot of ground.

Foundation and Pharmacist Mutual announce scholarship award winners

Published February 4, 2022

High-fives to Ryan DeGuzman and Kaitlin Martin!

Topi-Click to match new contributions to save cBHT!

Published February 4, 2022

For the entire month of February, Topi-Click is matching every new contribution dollar-for-dollar up to $10,000.

Bring your team to EduCon and you could save big

Published January 31, 2022

We’ve even got a great deal: If more than three folks from the same pharmacy team register, we’ll give all three a 15% discount!

USP BUD changes: ‘Where’s the patient benefit?’ ask presenters in prescriber briefing

Published January 24, 2022

APC and NCPA‘s briefing explained USP’s proposal to restrict beyond-use dates in Chapters <795> and <797> — and the ramifications for patients.

Rep. Cammack visits Wells Pharmacy

Published January 24, 2022

Florida Congresswoman Kat Cammack paid a visit to Wells Pharmacy in Ocala, Fla., on January 5.

The latest on animal compounding and GFI #256

Published January 24, 2022

Members of Congress express concerns to FDA Commissioner Janet Woodcock.

The vaccine mandate and your employees

Published January 19, 2022

SCOTUS upheld the CMS vaccine mandate — does it affect your facility?

USP extends BUD comment deadline

Published January 14, 2022

APC, APhA, and NCPA made the request in December.

Urge prescribers to attend this briefing on proposed BUDs changes

Published January 12, 2022

They may not know about USP’s proposal and the effects on their patients.

Associations ask USP to extend comment deadline

Published January 12, 2022

In December, APC, APhA, and NCPA sent a joint letter to Brenda Jensen, chair of USP’s Compounding Expert Committee.

NCPA and APC to brief prescribers on BUD issues Jan. 20

Published January 5, 2022

Prescribers need to know the potential issues with USP’s proposals for beyond-use dates on compounded medication.

APC members defend cBHT on TV

Published January 4, 2022

Shawn and Tara pushed back against misinformation about cBHT ... and looked good doing it.

Check out cover guy Gopesh Patel!

Published January 3, 2022

He’s on the December America’s Pharmacist mag.

Wishing you all a wonderful New Year’s

Published December 22, 2021

"Not a creature was stirring," indeed.

Congressmembers to FDA: On cBHT, remember the patient

Published December 17, 2021

22 members of Congress urged FDA to “craft patient-centered policies that preserve treatment options” related to compounded hormones.

Is your board of pharmacy aware of USP’s BUD proposals?

Published December 17, 2021

Mention this letter to your pharmacy board members and executive director.

Everyday Health has published our compounded hormones series!

Published December 17, 2021

It debuted last week.

Helping Kentuckians

Published December 17, 2021

The Kentucky Society of Association Executives has directed those who want to help to this list of local charity organizations.

BUD restrictions: We need your real-world examples

Published December 17, 2021

How do you think currently proposed revisions to USP Chapters 795 and 797 will affect your patients and pharmacy practice? We need to hear from you, and soon!

Small gesture, big impact

Published December 17, 2021

One small thing you can do to help promote APC’s campaign to save compounded hormones.

Letco cBHT fundraiser engages new donors

Published December 17, 2021

350 pharmacies donated to APC’s effort to save compounded hormones!

Are we one-and-done on the cBHT media campaign?

Published December 10, 2021

The dollars are not yet rolling in for 2022. And it has us worried.

Hospital compounding GFI “strikingly inconsistent,” APC tells FDA

Published December 10, 2021

APC’s comment letter was submitted in response to FDA’s proposed Revised Draft Guidance for Industry.

« Newer EntriesOlder Entries »